Top Markets
#1 Akedo Akedo +61.14%
#2 Glidr Glidr +51.75%
#3 DOVU DOVU +49.20%
#4 Cross Cross +47.31%
#5 Black Phoenix Black Phoenix +34.31%
#6 Velvet Velvet +29.27%
#7 OVERTAKE OVERTAKE +25.19%
#8 Not in Employment, Education, or Training Not in Employment, Education, or Training +16.05%
#9 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +14.98%
#10 Movement Movement +14.11%
Coin of the day
Akedo Akedo
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
Lipidor AB (publ) Lipidor AB (publ)

Lipidor AB (publ)

LIPI
Rang in Aktien #39103
Lipidor AB (publ), a Swedish pharmaceutical company founded in Danderyd in... Lipidor AB (publ), a Swedish pharmaceutical company founded in Danderyd in 2009, specializes in developing medicinal products. Its core business centers on creating treatments for various skin conditions, including psoriasis, bacterial skin infections, and atopic dermatitis. The company's product pipeline includes AKP-01, which is currently in Phase III clinical trials for psoriasis, while other formulations like AKP-02 (also for psoriasis) and AKP-03 and AKP-07 (for eczema) are in earlier, preclinical development stages. Beyond its own drug candidates, Lipidor manufactures and supplies active pharmaceutical ingredients (APIs). These APIs are incorporated into products addressing a broad spectrum of therapeutic applications, such as managing psoriasis, microbial infections, inflammation, fungal issues, local pain relief, acne, wound healing, eczema, and migraines. Lipidor also caters to the animal health market, offering a line of spray-on skin care products for dogs, cats, and horses. Additionally, it develops consumer health items designed for purposes like antibacterial action, antiseptic care, moisturizing, disinfection, and treating acne and warts. In a key strategic alliance, Lipidor has partnered with Cannassure Therapeutics Ltd. This collaboration aims to advance topical medicinal cannabis products specifically formulated to alleviate skin inflammations and psoriatic lesions.
Aktienkurs
$0.02243487
Zuletzt synchronisiert: 2025-06-04
Marktkapitalisierung
$650.09K
Veränderung (1 Tag)
0.39%
Veränderung (1 Jahr)
0.00%
Land
SE
Handel Lipidor AB (publ) (LIPI)

Kategorie

Healthcare
Aktien-Split-Historie für Lipidor AB (publ) (LIPI)
Die Aktie Lipidor AB (publ) (Symbol: LIPI) durchlief insgesamt 1 Aktiensplits.
Der letzte Aktiensplit fand am May 24, 2024 statt.
Eine LIPI-Aktie, die vor dem May 24, 2024 gekauft wurde, entspricht heute 3.811 LIPI-Aktien.
Liste der Aktiensplits
Jahr Aktien-Split Multiplikator Kumulierter Multiplikator
2024-05-24 3811:1000 x3.811 x3.811
Aktiensplits ähnlicher Unternehmen oder Wettbewerber
Unternehmen Anzahl der Aktiensplits Kumulierter Multiplikator Land
Eli Lilly and Company Eli Lilly and Company
Eli Lilly and Company
LLY.US
 4 x15
US
Johnson & Johnson Johnson & Johnson
Johnson & Johnson
JNJ.US
 7 x432
US
AbbVie Inc. AbbVie Inc.
AbbVie Inc.
ABBV.US
 0 -
US
Roche Holding AG Roche Holding AG
Roche Holding AG
RO.SW
 2 x10000
CH
Merck & Co., Inc. Merck & Co., Inc.
Merck & Co., Inc.
MRK.US
 7 x226
US